CN Patent

CN1083702A — 含赖氨酸氯胺烟酸盐的药用软胶囊

Assigned to Roemmers SAICF · Expires 1994-03-16 · 32y expired

What this patent protects

长期稳定、易用标准制造设备生产并且能提供口服后就立即产生治疗活性的快速作用且比目前市场上出售的赖氨酸氯胺烟酸盐片剂的有害副作用小的软明胶胶囊。其含作为活性成分的赖氨酸氯胺烟酸盐的填充物基于含平均分子量为约200—1000的聚乙二醇的亲水性基质、甘油(占3—10重量％)和水 (5—15％)。它们对疼痛和炎症有效。

USPTO Abstract

长期稳定、易用标准制造设备生产并且能提供口服后就立即产生治疗活性的快速作用且比目前市场上出售的赖氨酸氯胺烟酸盐片剂的有害副作用小的软明胶胶囊。其含作为活性成分的赖氨酸氯胺烟酸盐的填充物基于含平均分子量为约200—1000的聚乙二醇的亲水性基质、甘油(占3—10重量％)和水 (5—15％)。它们对疼痛和炎症有效。

Drugs covered by this patent

mesalamine (MESALAMINE)

Patent Metadata

Patent number: CN1083702A
Jurisdiction: CN
Classification: —
Expires: 1994-03-16
Drug substance claim: No
Drug product claim: No
Assignee: Roemmers SAICF
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.